NR4A1 and neoplasm: For example, a patient with a HER2-negative, hormone receptor-positive tumor could be treated in the first line with several hormone treatments and with different chemotherapy drugs, such as taxanes, anthracyclines, vinorelbine, or capecitabine in combination with bevacizumab [5, 7, 8].